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The manufacture of human mesenchymal stem cells (hMSCs) for clinical applications requires an appropriate growth surface and
an optimized, preferably chemically defined medium (CDM) for expansion. We investigated a new protein/peptide-free CDM that
supports the adhesion, growth, and detachment of an immortalized hMSC line (hMSC-TERT) as well as primary cells derived from
bone marrow (bm-hMSCs) and adipose tissue (ad-hMSCs). We observed the rapid attachment and spreading of hMSC-TERT cells
and ad-hMSCs in CDM concomitant with the expression of integrin and actin fibers. Cell spreading was promoted by coating the
growth surface with collagen type IV and fibronectin.The growth of hMSC-TERT cells was similar in CDM and serum-containing
mediumwhereas the lag phase of bm-hMSCs was prolonged in CDM. FGF-2 or surface coating with collagen type IV promoted the
growth of bm-hMSCs, but laminin had no effect. All three cell types retained their trilineage differentiation capability in CDM and
were detached by several enzymes (but not collagenase in the case of hMSC-TERT cells). The medium and coating did not affect
detachment efficiency but influenced cell survival after detachment. CDM combined with cell-specific surface coatings and/or
FGF-2 supplements is therefore as effective as serum-containing medium for the manufacture of different hMSC types.
1. Introduction
Human mesenchymal stem/stromal cells (hMSCs) are often
used for cell therapy because they offer many advantageous
characteristics [1]. Before therapeutic use, hMSCs must be
expanded to produce the number of cells needed per patient
and per dose (at least 1-2 × 106 hMSCs per kg) [2].The growth
of hMSCs is anchorage-dependent, and the interactions
among the growth surface, cells, and surrounding medium
are therefore important for the manufacture of suitable
numbers of healthy cells.
Cell adhesion is necessary for hMSC expansion and is
driven by both nonspecific and specific interactions.
Rounded cells in suspension initially attach to the surface due
to complementary electrostatic/ionic forces and the growth
surface then interacts with cell surface integrins, the
principal receptors mediating cell-matrix adhesion [3].
Integrin activation results in the formation of heterodimers,
which initiate signaling cascades that activate downstream
genes and ultimately regulate cell morphology and behavior.
The cell flattens and spreads due to the activation of protein
kinase C (PKC) and the subsequent accumulation of focal
adhesion kinase (FAK) and actin filaments at the leading
edges of the cells.The completion of cell spreading and strong
adhesion to the surface, which is required for proliferation,
is characterized by the inactivation of PKC and the cross-
linking of actin to defined intracellular stress fibers along
with FAK located at the focal adhesion sites. The actin forms
a stable cytoskeleton, which maintains the cell in its adherent
spread state [4, 5].
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Serum (usually bovine, sometimes human) is often
included in hMSC expansionmedia to promote cell adhesion
because it contains many attachment-promoting proteins
(e.g., collagens, fibronectin, laminins, and vitronectin) as
well as hormones and lipids that stimulate cell prolifer-
ation in vitro [6]. Serum causes problems when hMSC
expansion must be carried out according to good manu-
facturing practice (GMP) because hMSCs in the clinic are
considered advanced therapy medicinal products (ATMPs)
by the European Medicines Agency (EMA) and US Food
andDrugAdministration (FDA).These agencies recommend
the avoidance of any raw materials derived from mammals,
including serum, to reduce the risk of contamination when
using ATMPs [7].
The regulatory pressure to eliminate serum has resulted
in several innovations [8]. In addition to serum-containing
medium (SCM, 10–20% serum) and reduced serum medium
(1–5% serum, fortified with insulin, transferrin, and other
nutrients), several categories of serum-free medium have
been developed including (a) serum-free medium, with
additional mammalian hormones, growth factors, proteins,
and polyamines; (b) protein-free medium, containing pep-
tide fragments from the enzymatic or acid hydrolysis
of proteins derived from animals or plants; (c) recom-
binant xeno-free medium, containing recombinant pro-
teins/hormones/compounds and chemically defined lipids;
and (d) chemically defined medium (CDM) which is a
protein-free basal medium containing only low-molecular-
weight additives, synthetic peptides or hormones, and a few
recombinant or synthetic versions of proteins. Several in-
house serum-free media have been developed for hMSC
expansion, and these often contain additional factors such
as bovine/human serum albumin, insulin, transferrin, hor-
mones (e.g., progesterone, hydrocortisone, and estradiol),
growth factors (e.g., bFGF, TGF-𝛽, EGF, or PDGF), or
heparin [9–18]. Commercial products are also available for
this purpose, and although the full ingredient lists are
not disclosed they also tend to include a selection of the
components listed above. To our knowledge, however, the
only protein/peptide-free CDM for hMSC expansion is the
StemCell1 medium from Cell Culture Technologies, which
completely lacks any proteinaceous components and each
component is a defined concentration of a low-molecular-
weight compound (between 50 and 250Da, except one
>1000Da) that can be identified by its Chemical Abstracts
Service registration number.
The absence of growth and attachment-promoting pro-
teins in CDM may necessitate the use of protein coatings
on the surface of tissue culture plasticware to encourage cell
adhesion. Many serum proteins can be used as coatings,
including native or denatured collagen, fibronectin, laminin,
and vitronectin. Each protein is recognized by specific
integrin heterodimers: native collagen by 𝛼
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expression in hMSCs differs by source, but hMSCs should
bind via integrin receptors to each of the coatings listed above.
We investigated the attachment and spreading behavior of
an immortalized hMSCcell line (hMSC-TERT) and two types
of primary hMSCs derived from bone marrow (bm-hMSCs)
and adipose tissue (ad-hMSCs) in the CDM StemCell1. We
tested different protein coatings to determinewhichwere able
to promote the adhesion and growth of these three cell types
in CDM. We also determined whether cells growing on the
different coatings differ in terms of their detachment behavior
and response to different detachment enzymes.
2. Materials and Methods
2.1. Cell Lines. We used primary hMSCs from bone marrow
(bm-hMSCs, passages 3–10) kindly provided by M. Rook,
Merck Millipore, Bedford, MA, USA, and from adipose
tissue (ad-hMSCs, passages 3–10) kindly provided by F.
Ehlicke, University of Wu¨rzburg, Wu¨rzburg, Germany. The
immortalized cell line hMSC-TERT [22] (passages 74–80)
was kindly provided by M. Kassem, University of Southern
Denmark, Odense, Denmark.
2.2. Media. We used Eagle’s minimal essential medium
(EMEM) supplemented with 2mM L-glutamine and 10%
standardized fetal bovine serum (FBS, Article no. S0615) as
our standard SCM.We used StemCell1 medium (Cell Culture
Technologies, Gravesano, Switzerland) supplemented with
2mML-glutamine as our CDM.Themedia were further sup-
plemented with 8 ng/mL recombinant human basic fibrob-
last growth factor (bFGF; Article no. W1370950050) when
required. Unless otherwise specified, all components were
purchased from Biochrom (Berlin, Germany).
2.3. Routine Cell Expansion and Adaption to CDM. Cry-
oconserved hMSC-TERT cells (10% DMSO, 90% FBS) and
primary hMSCs were thawed and cultivated in tissue flasks
(Sarstedt, Nu¨mbrecht, Germany) containing EMEM with
seeding densities between 5000 and 10,000 cells cm−2 at 37∘C,
in a 5% CO
2
humidified atmosphere. Passaging was car-
ried out at 80–90% confluence using 0.25mgmL−1 trypsin-
EDTA. CDM adaptation after the first passage was carried
out using a mixture of 50% SCM and 50% CDM, and subse-
quently 100% CDM was used in Advanced TC™ tissue flasks
(Greiner Bio-One, Kremsmu¨nster, Austria). All subsequent
passaging was carried out using 25% conditioned medium
from earlier cultures. The medium was replaced with 50%
fresh medium every 3-4 days. Cells were passaged at least
twice in CDM alone before starting the experiments.
2.4. Coating the Six-Well Plates. Collagen IV (human, C7521),
fibronectin (bovine, F1141), laminin (murine, L2020), and
vitronectin (human, SRP3186) were obtained from Sigma-
Aldrich Laborchemikalien GmbH (Seelze, Germany). Each
protein was applied to six-well plates overnight at 4∘C to
achieve a coating density of 5 𝜇mol cm−2. A set of plates was
coated with 10% (v/v) FBS as a positive control.
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2.5. Analysis of Cell Attachment and Spreading. The cells were
suspended either in SCM or in CDM and plated with 7000
(hMSC-TERT), 8000 (bm-MSCs), or 3000 (ad-MSCs) cells
cm−2 in coated or noncoated six-well plates. Attachment was
analyzed for 5 h by counting the adherent and suspended
cells every hour. Spreading was analyzed by counting the
spread cells on microscopic images and defined as previously
described [24].
2.6. Immunofluorescence Staining of the Cytoskeleton and Cell
Surface Integrin 𝛼4. Cells were grown for 24 h either in SCM
or in CDM on coated or noncoated six-well plates. We fixed
the cells by removing the medium, gently washing with 2mL
PBS, and incubating with acetone (Carl Roth, Karlsruhe,
Germany) for 10min at −20∘C. After two washes with
PBS, the sample was incubated with 2mL blocking solution
(10mgmL−1 BSA in PBS) for 30min at room temperature.
The sample was again washed twice and then incubated with
a 1 : 80 dilution of Alexa Fluor® 555 Phalloidin (Life Tech-
nologies, Darmstadt, Germany, A340555) or a 1 : 200 dilution
of DyLight 488 integrin 𝛼
4
antibody MM0417-2L30 (R&D
SystemsGmbH,Wiesbaden, Germany, NBP2-11738G) in PBS
for 2 h at room temperature in the dark. Finally, the nuclei
were counterstained with DAPI (AppliChem, Darmstadt,
Germany) and the sample was embedded in Mowiol (Carl
Roth) according to the manufacturers’ recommendations.
2.7. Analysis of Cell Growth. The cells were seeded in six-
well plates (coated or noncoated) at a density of 7000-10,000
cells cm−2 and grown in 2mL SCM or CDM for up to 8
d at 37∘C in a 5% CO
2
humidified atmosphere. Cells were
counted under the microscope every day. The growth rate 𝜇
was determined during the exponential growth phase using
the following equation:
𝜇 [
1
ℎ
] =
ln (𝑋
2
) − ln (𝑋
1
)
𝑡
2
− 𝑡
1
. (1)
2.8. Differentiation of Expanded Cells. The cells were dif-
ferentiated using StemMACS AdipoDiff, ChrondroDiff, or
OsteoDiff media (Miltenyi Biotec, Bergisch Gladbach, Ger-
many) according to the manufacturer’s recommendations.
After differentiation, the cells were fixed with 4% para-
formaldehyde (Carl Roth) for 30min at room temperature.
Adipogenic differentiation was confirmed by nil red staining
of the fat droplets as previously described [25]. Finally, the
sample was embedded with Mowiol (Carl Roth) accord-
ing to the manufacturer’s recommendations. Chondrogenic
differentiation was confirmed by the immunofluorescence
staining of collagen type II as described [26]. Osteogenic
differentiation was confirmed using the OsteoImage Miner-
alization Assay (Lonza, Basel, Switzerland) according to the
manufacturer’s recommendations.
2.9. Analysis of Cell Detachment. The cells were suspended
in SCM or CDM, seeded at a density of 50,000 cells cm−2
in coated or noncoated six-well plates and incubated at 37∘C
in a 5% CO
2
humidified atmosphere until attachment was
Table 1: Properties of the enzymes used for cell detachment.
Detachment enzyme Manufacturer Incubationtime (min)
Accutase Sigma-Aldrich 10
Collagenase PAA LaboratoriesGmbH 60
Prolyl-specific peptidase (PsP) [23] 40
Trypsin PAA 10
observed. Each well was washed twice with 1mL PBS to
remove the medium. The cells were incubated with 0.5mL
detachment enzyme solution (supplemented with 0.02%
EDTA if necessary) as shown in Table 1. The detachment
reaction was stopped by adding 1.5mL SCM, the solution
was centrifuged (500× g, 5min, room temperature), and
the remaining cell pellet was resuspended in 0.5mL SCM.
Cell number and viability were determined by trypan blue
staining.
3. Results
3.1. Attachment and Spreading of hMSC-TERT Cells and
Primary hMSCs. Efficient cell attachment and spreading
on the growth surface are necessary to expand anchorage-
dependent hMSCs. In CDM, the hMSC-TERT cells com-
pletely attached within 4 h regardless of the presence/absence
or type of surface coating. We observed minor surface-
dependent differences in the attachment rate; for example,
the cells attached more slowly on the collagen IV coating.
Nevertheless, there was little difference in the attachment
behavior of hMSC-TERT cells growing in SCM and CDM.
In contrast, the spreading of the cells in CDM was positively
influenced by the protein coatings. In the absence of coating,
only 8% of the attached cells spread after 5 h, whereas cells
seeded on collagen type IV and fibronectin spread at similar
rates to those seeded on FBS or in SCM (Figure 1). The
immunofluorescence staining of the cytoskeleton and cell
surface integrins revealed that hMSC-TERT cells growing in
CDM on surfaces coated with collagen type IV or fibronectin
contained better-organized F-actin fibers than cells growing
on other surfaces and also expressed integrin 𝛼
4
at a higher
level (Figure 2).
The bm-hMSCs attached poorly in CDM (Figure 3(a))
but even in SCM complete attachment took up to 24 h. Only
a few bm-hMSCs had attached after 5 h in CDM and no
spreading was observed within this time period.The attached
bm-hMSCs were thin and elongated on each of the coatings
and no lamellipodia were observed. Our results showed that
no coating was preferable for the attachment or spreading of
these cells in CDM, but without coating the attached cells
tended to detach again and become rounded (Figure 3(b)).
In contrast, the ad-hMSCs attached rapidly in CDM and
more than 90% of the cells had attached within 2 h, regardless
of the presence/absence or type of coating. Within 4 h, 59%
of the cells had spread on the collagen type IV surface
whereas almost 100% of cells had spread on the fibronectin,
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Figure 1: Spreading of hMSC-TERT cells on different surface
coatings. The hMSC-TERT cells were grown on different coatings
either in serum-containingmedium (SCM) or in chemically defined
medium (CDM). The cells were analyzed by microscopy and those
showing at least three lamellipodia were defined as spread. Each
measurement was taken in triplicate (𝑛 = 3).
laminin, and vitronectin surfaces after the same amount of
time. The immunofluorescence staining showed that all the
expanded ad-hMSCs in CDM expressed integrin 𝛼
4
, but the
F-actin fibers were not as well organized and distinct as those
observed in the cells cultivated in SCM (Figure 2).
3.2. Growth of hMSC-TERT Cells and Primary hMSCs. A
comprehensive investigation of hMSC-TERT growth behav-
ior in CDM initially showed that the choice of cell culture
plastic (CCP) had an enormous influence (Figure 4). In
standard CCP, the hMSC-TERT cells had a prolonged lag
phase and a slower growth rate (𝜇STD-CCP = 0.013 h
−1)
compared to cells growing in SCM (𝜇SCM = 0.020 h
−1). In
addition, the maximum density of cells growing on standard
CPP was 2.6-fold lower in CDM compared to SCM. On CPP
specially designed for compatibility with CDM cultivation
(CDM-CPP), the growth rate of the cells was similar in CDM
and SCM (𝜇CDM-CCP = 0.019 h
−1). Supplementing the CDM
with FGF-2 or coating the CPP with the proteins listed above
did not improve the growth rate any further.
The growth of bm-hMSCs in CDM was only tested using
CDM-CPP. We found that cell growth was much slower in
the absence of coating (𝜇CDM-CCP 0.016 h
−1) when compared
to the growth rate in SCM (𝜇SCM 0.020 h
−1), and that the cell
number at the end of the cultivation was four times lower in
CDMcompared to SCM(Figure 5). For both primary hMSCs,
supplementing the CDM with FGF-2 significantly improved
the cell growth rate (𝜇FGF2 = 0.019 h
−1), but the cell number at
the end of the cultivation in CDMwas only half that achieved
using SCM. This probably reflects the duration of the lag
phase, which is 48 h longer in CDM compared to SCM. The
nature of coating also affected the growth rate of bm-hMSCs
in CDM; for example, laminin did not promote cell growth
any better than uncoated plates, whereas collagen type IV
improved the bm-hMSC growth rate to the same extent as
supplementing the medium with FGF-2.
3.3. Differentiation Potential of hMSC-TERT Cells and Pri-
mary hMSCs in CDM. Trilineage differentiation potential is
a minimal criterion for the therapeutic use of hMSCs, so
we investigated whether the expansion of cells in CDM had
any influence on this property. We found that hMSC-TERTs,
bm-hMSCs, and ad-hMSCs each retained their ability to
differentiate into adipocytes, chondrocytes, and osteoblasts,
as determined by immunofluorescence staining (Figure 6).
3.4. Detachment of hMSC-TERT Cells and Primary hMSCs.
Detachment is also necessary for hMSC expansion and this
process should be efficient without causing cell damage.
Compared to hMSC-TERT cells grown in SCM, we found
that the same cells growing in CDM were more difficult to
detach with trypsin, Accutase, and PsP and that collagenase
was completely ineffective even if the surface of the flasks was
coated with collagen (Figure 7). For hMSC-TERT cells grown
in SCM, the coating had no influence on detachment with
trypsin or Accutase because both enzymes achieved almost
100% detachment. For hMSC-TERT cells grown in CDM,
trypsin and Accutase detached most cells from laminin-
coated surfaces. PsP was unable to detach hMSC-TERT cells
from surfaces coated with collagen type IV in either SCM or
CDM. This enzyme efficiently removed cells from all other
surfaces in both media, but the efficiency of cell detachment
from fibronectin was 50% lower in CDM compared to SCM.
Although CDM generally had little impact on detachment
efficiency, it did affect the viability of the detached cells.
For hMSC-TERT cells grown in CDM without a surface
coating, the viability fell substantially after detachment with
trypsin (80.7±3.3%), Accutase (87.2±2.0%), and collagenase
(83.8 ± 9.2%) but remained high after detachment with PsP
(97.4 ± 0.1%). In contrast, the cells grown without a surface
coating in SCM only lost viability following detachment with
collagenase (88.6 ± 1.9%).The bm-hMSCs could be detached
efficiently from each coating with any of the enzymes,
including collagenase.We observed no differences among the
four coatings, but detachment was slightly less efficient in the
absence of a coating.All detached cells remainedhighly viable
after detachment (Figure 8).
4. Discussion
4.1. Interaction between Cells and the Growth Surface. The
nature of the growth surface can have a profound effect on the
behavior of cultured cells, and we found that this was also the
case for three different types of hMSCs. Switching from SCM
to CDM affected the growth of hMSCs on standard tissue
culture plastic, but a specially modified surface designed for
compatibility with CDM improved the growth of hMSC-
TERT cells to the same extent as SCM, and coating this
surface with extracellular matrix (ECM) proteins or adding
FGF-2 to the medium did not improve growth any further.
The modified plastic surface is prepared by incubating it
with plasma, which provides more oxygen groups to increase
wettability, protein interactions, and thereby cell proliferation
[27]. The impact of further coating with ECM proteins
differed according to the cell type. Fibronectin promoted
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Figure 2: Immunofluorescence staining of the cytoskeleton and the cell surface integrin𝛼
4
in hMSC-TERT cells and primary adipose-derived
hMSCs (ad-hMSCs).The cells were grown on different coatings either in serum-containingmedium (SCM) or in chemically definedmedium
(CDM). After fixation, immunofluorescence staining was carried out showing F-actin in red, integrin 𝛼
4
in green, and nuclei in blue.
the adhesion of hMSC-TERT cells and ad-hMSCs, which
is not surprising because hMSCs express more fibronectin
receptors than receptors for each of the three other coatings
[20, 28]. Integrin 𝛼
4
is a major fibronectin receptor [19]
and we were able to detect this protein on the surface
of these hMSCs grown on fibronectin in SCM and CDM.
Interestingly, integrin 𝛼
4
was also present on hMSC-TERT
cells growing in CDM on collagen type IV although integrins
𝛼
1
, 𝛼
2
, 𝛼
10
, and 𝛼
11
combine with integrin 𝛽
1
to bind collagen
IV and integrin 𝛼
4
is not involved. Fibronectin and collagen
IV are interconnected, and collagen type IV educates other
ECM components and promotes the survival of fibroblasts
and tumor cells independent of its integrin and specificity
as a way to circumvent apoptosis [29, 30]. We observed this
growth-promoting effect for bm-hMSCs growing in CDM
on a collagen type IV coating. The coating had the same
positive impact as the growth factor FGF-2, which is known
to enhance the mitotic potential of hMSCs and increase their
growth rate and potential for self-renewal [31, 32].
4.2. The Behavior of the Three Types of hMSC in CDM.
The attachment and spreading kinetics of the three types of
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Figure 3: Attachment and spreading of primary bone marrow-derived hMSCs (bm-hMSCs) in chemically defined medium (CDM). (a)
Attachment was measured by counting the adherent and suspended cells. (b) The cells were analyzed by microscopy and those showing at
least three lamellipodia were defined as spread. Each measurement was taken in triplicate (𝑛 = 3).
hMSC in CDM were strongly dependent on the cell type.
Whereas the hMSC-TERT cells and ad-hMSCs attached and
spread rapidly, the adhesion of the bm-hMSC was slow and
inefficient. The latter were also slow to attach in SCM, which
suggests the effect is cell- or donor-dependent rather than
indicative of missing attachment-promoting proteins in the
CDM. Human MSCs from different sources differ in their
integrin profiles [33]; for example, hMSC-TERT cells express
integrins 𝛼
2
, 𝛼
4
, 𝛼
5
, 𝛼
6
, 𝛼
11
, 𝛼v, 𝛽1, and 𝛽5 [28], whereas
primary hMSCs express integrins 𝛼
1
, 𝛼
2
, 𝛼
3
, 𝛼
6
, 𝛼
7
, 𝛼
9
, 𝛼
11
,
and𝛽
1
[34], and this is likely to affect their adhesion behavior.
Importantly, cell vigor also depends on the age and health
of the donor. The bm-hMSCs were derived from an older
donor than the ad-hMSCs, which could explain their slow
attachment and proliferation compared to the ad-hMSCs
and the immortalized hMSC-TERT cells. To exclude donor-
dependent effects and confirm that the observed behavior
in CDM is genuinely cell-dependent, it will be necessary
to repeat the experiments using bm-hMSCs and ad-hMSCs
from at least five donors.
Strong adhesion is required for cell growth, so the
inefficient adhesion of the bm-hMSCs in CDM may explain
the long lag phase compared to the same cells grown in
SCM. The growth rate was improved by supplementing
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Figure 4: Growth of hMSC-TERT cells in chemically defined
medium (CDM). The cells were grown on standard cell culture
plastic (STD-CCP) or CDM-optimized CCP (CDM-CCP) in either
CDM (with or without FGF-2) or serum-containing medium
(SCM). Cell growth was analyzed by the counting and the mea-
surement of glucose consumption. Each measurement was taken in
triplicate (𝑛 = 3).
×10
4
2
4
6
8
10
12
C
ell
 co
nc
en
tr
at
io
n 
(c
el
ls/
cm
2
)
50 1000 200150
Time (h)
None, SCM
None, CDM
None, CDM + FGF-2
Laminin, CDM
Collagen IV, CDM
Figure 5: Growth of primary bone marrow-derived hMSCs (bm-
hMSCs) in chemically defined medium (CDM). The cells were
grown on coated or noncoated CDM-optimized cell culture plastic
either in CDM (with or without FGF-2) or in serum-containing
medium (SCM). Cell growth was analyzed by the counting and
the measurement of glucose consumption. Each measurement was
taken in triplicate (𝑛 = 3).
the medium with FGF-2 or coating the surface with collagen
type IV, but the lag phase could not be shortened. To confirm
this hypothesis, the adhesion strength of the cells should be
analyzed in future experiments, for example, by atomic force
microscopy [35].
The detachment behavior of the three types of hMSC was
also distinct and depended on the medium and the surface
coating. For cells grown in CDM, surface coating did not
improve the efficiency of detachment, but it did increase cell
viability after cell detachment indicating a protective effect.
Interestingly, the hMSC-TERT cells could not be detached
with collagenase, even if the cells were grown on a collagen-
coated surface, despite the fact that collagenase is often used
to isolate hMSCs from tissues [36]. In previous studies, we
showed that collagenase is not suitable for the detachment
of hMSC-TERT cells from glass surfaces because it primarily
cleaves cell-cell linkages and not cell surface linkages [37, 38].
In contrast to hMSC-TERT cells, the primary hMSCs could
easily be detached with collagenase and the other enzymes.
4.3. Influence of Surface Coating and the Medium on Stem
Cell Potency. All three hMSC types retained their stem cell
phenotype and capacity formultilineage differentiation when
expanded in CDM, showing that CDM is suitable for robust
hMSC expansion and does not contain soluble factors that
promote unwanted differentiation [39].
We did not determine whether the coating influences
the potency of hMSCs, but this must be considered because
certain ECM components can induce differentiation. For
example, fibronectin promotes cell spreading and prolifera-
tion while inhibiting adipogenic differentiation, but it plays a
pivotal role during osteogenic differentiation. Furthermore,
vitronectin and collagen type I can promote osteogenic
differentiation in hMSCs, whereas laminin can stimulate the
proliferation of hMSCs (although we could not confirm this
in our experiments) but suppresses chondrogenesis [40].This
shows that multiple ECM components can provide a suitable
attachment and growth surface for hMSCs, but these must be
chosen carefully to avoid unwanted differentiation during cell
expansion.
5. Conclusions
The manufacture of hMSCs for clinical applications requires
an appropriate choice of growth surface and expansion
medium. We have demonstrated that it is possible to expand
different primary hMSCs and an immortalized hMSC line
in protein/peptide-free CDM, which means that fewer sup-
plements are required than anticipated and that the cells can
survive in a basic medium. The cultivation of cells for a few
days or for one or two passages is not enough to declare a
robust serum-freemedium, because stem cells can proliferate
in basal medium [41]. Therefore, it will be necessary to
expand the hMSCs for longer periods to determine whether
the CDM is suitable for manufacturing. Nevertheless, the
behavior of each of the three cell types in CDM was distinct.
For example, the fibronectin coating was only advantageous
for ad-hMSC and hMSC-TERT attachment but did not affect
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Figure 6: Differentiation capacities of hMSC-TERT cells and primary adipose-derived hMSCs (ad-hMSCs). The cells were induced
to undergo adipogenic, chondrogenic, or osteogenic differentiation in commercial media after expansion in CDM. Differentiation was
confirmed by nil red staining (red, adipogenic), collagen type II immunostaining (green, chondrogenic), or hydroxyapatite staining (green,
osteogenic). The primary bone marrow-derived hMSCs (bm-hMSCs) behaved in a similar manner (data not shown).
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Figure 7: Detachment of hMSC-TERT cells using different
enzymes.The cells were grown to confluency in coated or noncoated
wells and were detached enzymatically. Cell detachment was ana-
lyzed by counting cells in suspension. Each experiment was carried
out in triplicate (𝑛 = 3).
bm-hMSCs. Furthermore, FGF-2 and collagen IV promoted
the growth of bm-hMSCs but not hMSC-TERT cells. It is not
yet possible to recommend a generally advantageous coating
or supplement for the expansion of each MSC type in CDM
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Figure 8: Detachment of primary bone marrow-derived hMSCs
(bm-hMSCs) using different enzymes. The cells were grown to
confluency in coated or noncoated wells and were detached
enzymatically. Cell detachment was analyzed by counting cells in
suspension. Each experiment was carried out in triplicate (𝑛 = 3).
because donor-dependent effects could not be excluded.
Therefore, more extensive studies with hMSCs from other
sources (e.g., umbilical cord) and with more donors per cell
type are necessary to determine whether general principles
can be drawn from these data. Efficient hMSCmanufacturing
Stem Cells International 9
requires a detailed understanding of the interactions among
the cells, the growth surface, and the cultivation medium.
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